DalsnaFinance › Analyst accuracy › Goldman Sachs › UTHR target
Goldman Sachs initiates United Therapeutics stock with sell rating
a Sell rating and a price target of $321.00
A fact about what Goldman Sachs published, as reported by Investing.com, not a recommendation from Dalsna Finance; Goldman Sachs is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.